Strategy to Find Molecular Signatures in a Small Series of Rare Cancers: Validation for Radiation-Induced Breast and Thyroid Tumors

• Nicolas Ugolin ,

  Contributed equally to this work with: Nicolas Ugolin, Catherine Ory

  Affiliation CEA, DSV, IRCM, SREIT, Laboratoire de Cancérologie Expérimentale, BP6, Fontenay-aux-Roses, France

  ⨯
• Catherine Ory ,

  Contributed equally to this work with: Nicolas Ugolin, Catherine Ory

  * E-mail: catherine.ory@cea.fr

  Affiliation CEA, DSV, IRCM, SREIT, Laboratoire de Cancérologie Expérimentale, BP6, Fontenay-aux-Roses, France

  ⨯
• Emilie Lefevre,

  Affiliation CEA, DSV, IRCM, SREIT, Laboratoire de Cancérologie Expérimentale, BP6, Fontenay-aux-Roses, France

  ⨯
• Nora Benhabiles,

  Affiliation CEA, DSV, IRCM, SREIT, Laboratoire de Cancérologie Expérimentale, BP6, Fontenay-aux-Roses, France

  ⨯
• Paul Hofman,

  Affiliations INSERM ERI-21, Nice, France, University of Nice-Sophia Antipolis, IFR 50, Nice, France, Laboratory of Clinical and Experimental Pathology and CHU-CRLCC-UNSA Tumour/Tissue Bank of Nice Area, Louis Pasteur Hospital, Nice, France

  ⨯
• Martin Schlumberger,

  Affiliation Department of Nuclear Medicine and Endocrine Oncology, Institut Gustave Roussy, Villejuif, France

  ⨯
• Sylvie Chevillard

  Affiliation CEA, DSV, IRCM, SREIT, Laboratoire de Cancérologie Expérimentale, BP6, Fontenay-aux-Roses, France

  ⨯